145 related articles for article (PubMed ID: 37022169)
1. Pharmacokinetics of Voriconazole in Peritoneal Fluid of Critically Ill Patients.
Lin XB; Hu XG; Tang ZX; Guo PH; Liu XM; Liang T; Xia YZ; Lui KY; Chen P; Tang KJ; Chen X; Cai CJ
Antimicrob Agents Chemother; 2023 May; 67(5):e0172122. PubMed ID: 37022169
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction.
Lin XB; Lui KY; Guo PH; Liu XM; Liang T; Hu XG; Tong L; Wu JJ; Xia YZ; Chen P; Zhong GP; Chen X; Cai CJ
Pharmacotherapy; 2022 Jan; 42(1):23-33. PubMed ID: 34655497
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous voriconazole in patients with liver dysfunction: A prospective study in the intensive care unit.
Lin XB; Huang F; Tong L; Xia YZ; Wu JJ; Li J; Hu XG; Liang T; Liu XM; Zhong GP; Cai CJ; Chen X
Int J Infect Dis; 2020 Apr; 93():345-352. PubMed ID: 32109625
[TBL] [Abstract][Full Text] [Related]
4. Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.
Grau S; Luque S; Campillo N; Samsó E; Rodríguez U; García-Bernedo CA; Salas E; Sharma R; Hope WW; Roberts JA
J Antimicrob Chemother; 2015 Oct; 70(10):2854-61. PubMed ID: 26180134
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics in China: The Dynamics of Intravenous Voriconazole in Critically Ill Patients with Pulmonary Disease.
Chen W; Xie H; Liang F; Meng D; Rui J; Yin X; Zhang T; Xiao X; Cai S; Liu X; Li Y
Biol Pharm Bull; 2015; 38(7):996-1004. PubMed ID: 26133710
[TBL] [Abstract][Full Text] [Related]
6. Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels.
Gautier-Veyret E; Fonrose X; Tonini J; Thiebaut-Bertrand A; Bartoli M; Quesada JL; Bulabois CE; Cahn JY; Stanke-Labesque F
Antimicrob Agents Chemother; 2015 Apr; 59(4):2305-14. PubMed ID: 25645831
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.
Lin XB; Hu XG; Xia YZ; Liu XM; Liang T; Chen X; Cai CJ
J Chemother; 2022 Jul; 34(4):272-276. PubMed ID: 34904531
[TBL] [Abstract][Full Text] [Related]
8. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
García-de-Lorenzo A; Luque S; Grau S; Agrifoglio A; Cachafeiro L; Herrero E; Asensio MJ; Sánchez SM; Roberts JA
Antimicrob Agents Chemother; 2016 Oct; 60(10):5914-21. PubMed ID: 27458229
[TBL] [Abstract][Full Text] [Related]
9. Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Wang B; Wang Y; Zhang L; Lu F; Zhang M; Xu Y
Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704741
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis.
Pérez Civantos DV; Robles Marcos M; Azanza Perea JR; Pazos Pacheco C; García-Montoto Pérez F; Jerez Gómez-Coronado V
Int J Infect Dis; 2019 Sep; 86():142-146. PubMed ID: 31330325
[TBL] [Abstract][Full Text] [Related]
11. Prospective Cohort Study of Micafungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-abdominal Infections.
Garbez N; Mbatchi L; Wallis SC; Muller L; Lipman J; Roberts JA; Lefrant JY; Roger C
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0230720. PubMed ID: 33846133
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-Abdominal Infections: A Prospective Cohort Study.
Garbez N; Mbatchi LC; Wallis SC; Muller L; Lipman J; Roberts JA; Lefrant JY; Roger C
Clin Pharmacokinet; 2022 May; 61(5):673-686. PubMed ID: 34931282
[TBL] [Abstract][Full Text] [Related]
14. Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans.
Schulz J; Michelet R; Zeitlinger M; Mikus G; Kloft C
Pharm Res; 2022 Dec; 39(12):3279-3291. PubMed ID: 36271205
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata.
Sanchis M; Capilla J; Castanheira M; Martin-Vicente A; Sutton DA; Fothergill AW; Wiederhold NP; Guarro J
Int J Antimicrob Agents; 2016 Apr; 47(4):286-8. PubMed ID: 26976780
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance.
Gioia F; Gomez-Lopez A; Alvarez ME; Gomez-García de la Pedrosa E; Martín-Davila P; Cuenca-Estrella M; Moreno S; Fortun J
Int J Infect Dis; 2020 Dec; 101():24-28. PubMed ID: 32937195
[TBL] [Abstract][Full Text] [Related]
17. Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients.
Li ZW; Peng FH; Yan M; Liang W; Liu XL; Wu YQ; Lin XB; Tan SL; Wang F; Xu P; Fang PF; Liu YP; Xiang DX; Zhang BK
Ther Drug Monit; 2017 Aug; 39(4):422-428. PubMed ID: 28604474
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of voriconazole and CYP2C19 phenotype for dose optimization in paediatric patients.
Hu L; Huang Q; Huang S; Feng Z
Eur J Clin Pharmacol; 2023 Sep; 79(9):1271-1278. PubMed ID: 37458772
[TBL] [Abstract][Full Text] [Related]
20. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
